The Newest Agenda of Global Pharma Congress 2014

April 9, 2014

SHANGHAI, April 9, 2014 /PRNewswire/ — In China NPC & CPPCC 2014, encouragement of transportation for pharmacy from API manufacturers to formulation manufacturers, formulation export, speed up new drug application and reform of basic drug bidding have become hot topics again.

(Photo: http://photos.prnasia.com/prnh/20140409/0861402219-a )

(Photo: http://photos.prnasia.com/prnh/20140409/0861402219-b )

Due to the success from 2 years of Pharma QbD, 4 years of Pharma Supply Chain, 4 years of Pharma Cold Chain and 4 years of NDDS organized by UBM, CPhI Conference will do the portfolio management of these pharmaceutical events to provide Global Pharma Congress 2014 during May 28-29, 2014 in InterContinental Shanghai Pudong, China. The three hot topics will be included in it and this event will make connection of different departments/functions of drug manufacturer. It is a good opportunity to accelerate communication of pharmaceutical industry and promote industry interaction.

Agenda At-A-Glance

                              Joint Plenary

    Day One Morning                   --Global pharmaceutical
                                      development and the requirement
                                      for innovation and quality
                                      --Medical reform and
                                      pharmaceutical industry
                                      development trend in NPC &
    (Morning of May 28)               --New regulation of CFDA for
                                      biologics and generics and New
                                      GMP/GSP for Pharma

    ---                              ---


    Day One Afternoon +
     Day Two                         Pharma QbD
                                      --QbD from idea to
                                      implementation, case study of
                                      QbD practice and experience
                                      sharing of DoE and RtR
    (Afternoon of May 28 + May 29)

    ---                              ---

    Pharma Cold Chain
    --Cold Chain management and
     temperature control under GSP
     guideline, advanced technology
     sharing and cooperation with

    Formulation Development & NDDS
    --Commercial values and
     techniques of formulation
     development, application of
     NDDS in formulation innovation

These hot topics will be presented

    --  Action and prospects from regulator: Updates of Three-years Test Plan of
        QbD from FDA and EMA
    --  Advocacy and requirement QbD from FDA, how to use QbD to save cost and
        improve efficiency for manufacturers?
    --  QbD application in APIs with guideline of ICH-Q11, updates of DMF
        making, synthesis process determining and process analysis
    --  Impacts of new GSP on pharma cold chain: storage temperature & humidity
        detection and new requirement of distribution & transportation
    --  Application of temperature control to reduce drug consumption and ensure
        product quality
    --  Build pharma logistics system and to integrate service platform from
        perspectives of IT & network technology and temperature layer
        distribution solutions
    --  Innovation of formulation: from the perspectives of design idea, R&D and
        market access
    --  Dissolution test and bioequivalence test to improve formulation quality
    --  Project approval of formulation innovation and key technology of dosage

Also the conference committee call for Speakers/Advisor Board

UBM is compiling a great roster of thought leaders and industry insiders for a program packed with timely insights, strategic views, and actionable items. If you would like the opportunity to speak at Global Pharma Congress or participate into advisor board, please submit your proposed topic, biography and contact information to conference producer:

Jessie Jiang (jessie.jiang@ubm.com / +86 21 6157 3933)

Visit the website learn more information www.pharm-congress.com

Contact us

Heron. Zhuang


Julia. Zhu



Source: PR Newswire

comments powered by Disqus